Tailored duration of adjuvant trastuzumab for human epidermal growth factor receptor 2-positive breast cancer

Yu, KD; Wang, X; Chen, WK; Fan, L; Mo, M; Chen, H

Yu, KD (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai Med Coll, Shanghai 200032, Peoples R China.; Chen, H (corresponding author), Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Ophthalmol, Shanghai 200031, Peoples R China.

NPJ PRECISION ONCOLOGY, 2020; 4 (1):

Abstract

We assumed that the effect of adjuvant trastuzumab on survival is mediated by the treatment time and we conducted this trial-level meta-regression to ......

Full Text Link